A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys

Bankiewicz, 1986, Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Life Sci., 39, 7, 10.1016/0024-3205(86)90431-5 Barone, 1986, Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions, Eur. J. Pharmacol., 123, 109, 10.1016/0014-2999(86)90694-1 Braun, 1986, Interaction of D-1 and D-2 dopamine receptors in the expression of dopamine agonist induced behaviors, 151 Crossman, 1987, MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms, Can. J. Neurol. Sci., 14, 428, 10.1017/S0317167100037859 Dipaolo, 1986, Chronic treatment with levodopa but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys, correlation with [3H]spiperone binding, Brain Res., 379, 286 Evarts, 1981, Reaction time in Parkinson's disease, Brain, 104, 167, 10.1093/brain/104.1.167 Forno, 1986, Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys, Ann. Neurol., 20, 449, 10.1002/ana.410200403 Guttman, M. and Calne, D.B., In vivo characterization of cerebral dopamine systems in human parkinsonism. In E. Tolosa and J. Jankovic (Eds.), Parkinson's disease and movement disorders, Urban and Schwartzenberg, Baltimore, in press. Jenner, 1986, MPTP induced parkinsonism in the common marmoset: Behavioral and biochemical effects, Adv. Neurol., 45, 183 Langston, 1987, Closer to Parkinson's disease: MPTP and the aging nervous system, Trends Pharmacol. Sci., 8, 7, 10.1016/0165-6147(87)90020-4 Langston, 1986, MPTP: current concepts and controversies, Clin. Neuropharmacol., 9, 485, 10.1097/00002826-198612000-00001 Mitchell, 1985, Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus ceruleus, Neurosci. Lett., 61, 195, 10.1016/0304-3940(85)90424-0 Pullman, 1988, Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease, Neurology, 38, 249, 10.1212/WNL.38.2.249 Ungerstedt, 1976, 6-Hydroxydopamine-induced degeneration of the nigro-striatal dopamine pathway: the turning syndrome, Pharmacol. Ther., 2, 37 Velasco, 1973, A quantitative evaluation of the effects of L-dopa on Parkinson's disease, Neuropharmacology, 12, 89, 10.1016/0028-3908(73)90079-8 Welford, 1958, Ageing and Human Skill, 107